Mucoadhesive patches of salbutamol sulphate for unidirectional buccal drug delivery: Development and evaluation

Current Drug Delivery

Volumn 8, Issue 4, 2011, Pages 416-425

  Puratchikody, A ^a   Prasanth, V V ^b   Mathew, Sam T ^c   Kumar, B Ashok ^d  

^a ANNA UNIVERSITY   (India)

^b Gautham College of Pharmacy   (India)

^c NOVARTIS HEALTHCARE PVT LTD   (India)

^d JADAVPUR UNIVERSITY   (India)

Author keywords

3 2 full factorial designs; Buccal drug delivery; Higuchi kinetics; Korsmeyer peppas equation; Mucoadhesive patches; Residence time; Salbu tamol sulphate; Swelling index

Indexed keywords

ACID SOLUBLE CHITOSAN; CHITOSAN DERIVATIVE; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 400; PLASTICIZER; POLYMER; POLYVINYL ALCOHOL; POVIDONE; SALBUTAMOL SULFATE; UNCLASSIFIED DRUG; WATER; WATER SOLUBLE CHITOSAN;

ACIDITY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FACTORIAL DESIGN; HUMAN; IN VITRO STUDY; MOLECULAR WEIGHT; MUCOADHESION; MUCOADHESIVE PATCH; NONHUMAN; PH; PRIORITY JOURNAL; SURFACE PROPERTY; THICKNESS;

ADHESIVENESS; ADMINISTRATION, BUCCAL; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; MOUTH MUCOSA; PERMEABILITY; POLYMERS; SALIVA; SURFACE PROPERTIES;

EID: 79959350436     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720111795768004     Document Type: Article

References (33)

1. WHO. World health statistics:www.who.org. (Accessed October 9, 2009).
2. Anandan, C.; Nurmatov, U.; Van Schayck, O.C.; Sheikh, A. Is the prevalence of asthma declining? Systematic review of epidemiol-ogical studies. Allergy., 2010, 65, 152-167. DOI:10.1111/j.1398-9995.2009.02244.x.
3. Coleman, A.J.; Somerville, A.R. The selective action of beta- adrenoceptor blocking drugs and the nature of beta1 and beta 2-adrenoceptors. B. J. Pharmacol., 1977, 59, 83-93.
4. Green, A.R.; Goodwin, G.M.; De Souza, R.J.; Heal, D.J. The beta 2-adrenoceptor agonists clenbuterol and salbutamol enhance the hypothermic action of 8-hydroxy-2-(di-n- propylamino) tetralin (8-OH-DPAT) in mice by a central mechanism. Neuropharmacology, 1986, 25, 21-24. DOI: 10.1016/0028-3908(86)90053-5.
5. Hochhaus, G.; Mollmann, H. Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol. Int. J. Clin. Pharmacol. Ther. Toxicol., 1992, 30,342-362.
6. Jones, D.S.; Woolfson, A.D.; Diokic, J.; Coulter, W.A. Development and mechanical characterization of bioadhesive semi-solid polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm. Res., 1996, 13,1734-1738. DOI: 10.1023/A: 1016413428473.
7. Hoogstraate, A.J.; Verhoef, J.C.; Tuk, B.; Pijpjers, A.; van Leengoed, L.A.; Verheijden, J.H.; Junginger, H.E.; Bodde. In-vivo buc-cal delivery of fluorescein isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs. J. Pharm. Sci., 1996, 85, 457-460. DOI: 10.1021/js950129k.
8. Perioli, L.; Ambrogi, V.; Giovagnoli, S.; Ricci, M.; Blasi, P.; Rossi, C. Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen. AAPS PharmSciTech., 2007, 8, E20-E27. DOI: 10.1208/pt0803054.
9. US Food and Drug administration. Safety alert for fentanyl buccal tablets. J Pain., 2008, 22, 47.
10. Sudhakar, Y.; Bandyopadhyay, A. K. Novel buccal adhesive tablets using Aloe vera L and Sinapis alba a promising option for improved bioavailability of diltiazem hydrochloride. PDA J Pharm Sci Technol., 2008, 62, 97-110.
11. No author reported. Fentanyl effervescent buccal tablets: new formulation for cancer patients with breakthrough pain: a second buc-cal formulation with minimal evaluation. Prescrire Int., 2009, 18, 205.
12. Cui, Z.; Mumper, R. J. Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits. Pharm. Res., 2002, 19, 947-953. DOI: 10.1023/A: 1016454003450.
13. Averineni, R.K.; Sunderajan, S.G.; Mutalik, S.; Nayak, U.; Shavi, G.; Armugam, K.; Meka, S.R.; Pandey, S.; Nayanabhirama, U. Development of mucoadhesive buccal films for the treatment of oral sub-mucous fibrosis: a preliminary study. Pharm. Dev. Technol., 2009,14, 199-207. DOI: 10.1080/10837450802498928.
14. Pongjanyakul, T.; Suksri, H. Alginate-magnesium aluminum silicate films for buccal delivery of nicotine. Colloids. Sur. B. Bio-interfaces., 2009, 74, 103-113. DOI:10.1016/j.colsurfb. 2009.06. 033.
15. Wong, C.F.; Yuen, K.H.; Peh, K.K. Formulation and evaluation of controlled release Eudragit buccal patches. Int.J. pharm., 1999, 178, 11-22. DOI: 10.1016/S0378-5173(98)00342-1.
16. Thimmasetty, J.; Pandey, G.S. Design and In-vivo evaluation of carvedilol buccal mucoadhesive patches. Pak. J. Pharm. Sci., 2008, 21,241-248.
17. Vamshi Vishnu, Y.; Chandrasekhar, K.; Ramesh, G.; Madhusudan Rao, Y.Development of mucoadhesive patches for buccal administration of carvedilol. Current Drug Delivery., 2007, 4,27-39.
18. Han, R.Y.; Fang, J.Y.; Sung, K.C.; Hu, O.Y. Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. Int. J. pharm., 1999, 177,201-209. DOI: 10.1016/S0378-5173(98)00343-3.
19. Bremecker, K.D.; Strempel, H.; Klein, G. Novel concept for a mucosal adhesive ointment. J. Pharm. Sci., 1984, 73, 548-552. DOI: 10.1002/jps.2600730429.
20. Karavana, S.Y.; Guneri, P.; Ertan, G. Benzydamine hydrochloride buccal bioadhesive gels designed for oral ulcers: preparation, rheological, textural, mucoadhesive and release properties. Pharm. Dev. Technol., 2009,14, 623-631.
21. Pate, V.M.; Prajapati, B.G.; Patel, M.M. Design and characterization of chitosan-containing mucoadhesive buccal patches of propranolol hydrochloride. Acta. pharm., 2007, 57, 61-72.
22. Khanna, R.; Agarwal, S.P.; Ahuja, A. Preparation and evaluation of mucoadhesive buccal films of clotrimazole for oral Candida infections. Indian. J. Pharm. Sci., 1997, 59,299-305.
23. Bottenberg, P.; Cleymaet, R.; de Muynck, C; Remon, J.P.; Coomans, D.; Michotte, Y.; Slop, D. Development and testing of bioadhesive fluoride containing slow release tablets for oral use. J. Pharm. Pharmacol, 1991, 43, 457-464.
24. Fumihiko, N.; Ryoko, O.; Yoshiharu, M.; Tsuneji, N. In-vitro and in-vivo nasal mucoadhesion of some water-soluble polymers. Int. J. pharm., 1996, 134,173-181. DOI: 10.1016/0378-5173(95)04416-7.
25. Hughes, L.; Gehris Rohm, A.; Haas. A new method of characterizing the buccal dissolution of drugs. Research Laboratories., Spring House, USA. Available online at www.rohmhaas.com/ionex-change/doc/buccal_dissolution.pdf. (accessed on 15 Oct 2010).
26. Nafee, N.A.; Boraie, M.A.; Ismail, FA.; Mortada, L.M. Design and characterization of mucoadhesive buccal patches containing ce-tylpyridinium chloride. Acta. Pharm., 2003,53, 199-212.
27. Mathew, S.T.; Devi, S.G.; Prasanth, V.V.; Vinod, B. Formulation and in vitro-in vivo evaluation of ketoprofen-loaded albumin microspheres for intramuscular administration. J. Microencapsul., 2009, 26, 456-469.
28. Mukherjee, B.; Mahapatra, S.; Gupta, R.; Patra, B.; Tiwari, A.; Arora, P. A comparison between povidone-ethylcellulose and po-vidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation. Eur. J.Pharm. Biopharm., 2005, 59,475-483. DOI: 10.1016/j.ejpb.2004.09.009.
29. thEd.; Pharmaceutical Press: Washington, 2009.
30. Peppas, N.A.; Buri, PA. Surfaceinterfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Control. Release., 1985, 2, 257-275. DOI: 10.1016/0168-3659(85)90050-1.
31. Panomsuk, S. P.; Hatanaka, T.; Aiba, T.; Katayama, K; Koizumi, T. A study of the hydrophilic cellulose matrix: effect of drugs on the swelling properties. Chem. Pharm. Bull., 1995,126, 147-153.
32. Lucy, S.C.W.; Paul, W.S.H.; Lee, F.W. Matrix swelling: A simple model describing the extent of swelling of HPMC matrices. Int. J. pharm., 1995, 116, 159-168. DOI: 10.1016/0378-5173(94)00285-D.
33. Haesun, P.; Joseph, R.R. Mechanisms of bioadhesion of poly (acrylic acid) hydrogels, Pharm. Res., 1987, 4,457-464. DOI:10.1023/A: 1016467219657.